Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 2/3 1

Status

Completed 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 6Lymphoid 4Myeloid 2Dermatologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Leukemia, Myeloid, Acute 12Myelodysplastic Syndromes 8Leukemia 8Myeloproliferative Disorders 6Lymphoma, Non-Hodgkin 6Leukemia, Lymphocytic, Chronic, B-Cell 6Recurrence 5Primary Myelofibrosis 5Lymphoma, T-Cell 5Lymphoma 5Hodgkin Disease 5Multiple Myeloma 4Graft vs Host Disease 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Follicular 3Leukemia, Prolymphocytic, T-Cell 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Prostatic Neoplasms 2Pancreatic Neoplasms 2Myelodysplastic-Myeloproliferative Diseases 2Lymphoma, T-Cell, Peripheral 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Leukemia, Myeloid, Accelerated Phase 2Burkitt Lymphoma 2Breast Neoplasms 2

Interventions

Cyclophosphamide 43Tacrolimus 39Methotrexate 30Cyclosporine 28Mycophenolic Acid 25fludarabine phosphate 22Antilymphocyte Serum 22Melphalan 20Busulfan 20Sirolimus 18Methylprednisolone 18Radiotherapy 17Peripheral Blood Stem Cell Transplantation 17fludarabine 15Whole-Body Irradiation 15Filgrastim 14Thiotepa 8Rituximab 8thymoglobulin 7Etoposide 7Granulocyte Colony-Stimulating Factor 6Cord Blood Stem Cell Transplantation 6Transplantation 5Therapeutics 5Stem Cell Transplantation 5Prednisone 5Flow Cytometry 5Cyclosporins 5Alemtuzumab 5ruxolitinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Graft vs Host Disease × ruxolitinib × Lymphoid × Clear all
NCT07356245 2026-04-15

Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting
44 enrolled
DermatologicLymphoidOther hematologic neoplasm

Graft vs Host Disease, Leukemia, Lymphoma, Leukemia, Prolymphocytic, T-Cell, Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT07297914 2025-12-22

FORUM2

Bambino Gesù Hospital and Research Institute

Phase 2/3 Not yet recruiting
1,000 enrolled
LymphoidOther hematologic neoplasm

Graft vs Host Disease, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03774082 2025-12-11

REACH 5

Novartis

Phase 2 Completed
46 enrolled 21 charts
Lymphoid

Bronchiolitis Obliterans Syndrome, Graft vs Host Disease, Lymphoma, Follicular

NCT04669210 2025-07-04

PTCyRuxo

St. Petersburg State Pavlov Medical University

Phase 2 Completed
128 enrolled
LymphoidOther hematologic neoplasm

Graft vs Host Disease, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡